Hilton, Douglas J <br/><br/>
Mutational inhibition of c-Myb or p300 ameliorates treatment-induced thrombocytopenia.  [electronic resource] 

 -  Blood  May 2009 
 - 5599-604 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2008-12-195255  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--adverse effects<br/>Bone Marrow Transplantation--rehabilitation<br/>Cells, Cultured<br/>Cytoprotection--drug effects<br/>Down-Regulation--genetics<br/>E1A-Associated p300 Protein--genetics<br/>Fluorouracil--pharmacology<br/>Genes, myb<br/>Mice<br/>Mice, Transgenic<br/>Mutation--physiology<br/>Neoplasms--drug therapy<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Receptors, Thrombopoietin--genetics<br/>Thrombocytopenia--chemically induced<br/>bcl-X Protein--genetics